These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 17476552)
1. Is OPTAx useful for monitoring the effect of stimulants on hyperactivity and inattention? A brief report. Tabori-Kraft J; Sørensen MJ; Kaergaard M; Dalsgaard S; Thomsen PH Eur Child Adolesc Psychiatry; 2007 Aug; 16(5):347-51. PubMed ID: 17476552 [TBL] [Abstract][Full Text] [Related]
2. Attention-deficit/hyperactivity disorder or hyperactivity in preschool children. Thompson M Br J Hosp Med (Lond); 2007 Jul; 68(7):356-9. PubMed ID: 17663305 [TBL] [Abstract][Full Text] [Related]
3. Objective measurement of hyperactivity, impulsivity, and inattention in children with hyperkinetic disorders before and after treatment with methylphenidate. Heiser P; Frey J; Smidt J; Sommerlad C; Wehmeier PM; Hebebrand J; Remschmidt H Eur Child Adolesc Psychiatry; 2004 Apr; 13(2):100-4. PubMed ID: 15103535 [TBL] [Abstract][Full Text] [Related]
4. ADHD and substance use disorders: developmental aspects and the impact of stimulant treatment. Wilson JJ Am J Addict; 2007; 16 Suppl 1():5-11; quiz 12-3. PubMed ID: 17453602 [TBL] [Abstract][Full Text] [Related]
5. Predictive utility of childhood diagnosis of ICD-10 hyperkinetic disorder: adult outcomes in the MTA and effect of comorbidity. Arnold LE; Roy A; Taylor E; Hechtman L; Sibley M; Swanson JM; Mitchell JT; Molina BSG; Rohde LA Eur Child Adolesc Psychiatry; 2019 Apr; 28(4):557-570. PubMed ID: 30232561 [TBL] [Abstract][Full Text] [Related]
6. Predictive validity of DSM-IV and ICD-10 criteria for ADHD and hyperkinetic disorder. Lee SI; Schachar RJ; Chen SX; Ornstein TJ; Charach A; Barr C; Ickowicz A J Child Psychol Psychiatry; 2008 Jan; 49(1):70-8. PubMed ID: 17979965 [TBL] [Abstract][Full Text] [Related]
7. The possible effect of methylphenidate on kleptomania in a school-age girl with attention-deficit/hyperactivity disorder. Yılmaz S; Bilgiç A Eur Child Adolesc Psychiatry; 2014 May; 23(5):361-3. PubMed ID: 24122344 [No Abstract] [Full Text] [Related]
8. Predictive validity of ICD-10 hyperkinetic disorder relative to DSM-IV attention-deficit/hyperactivity disorder among younger children. Lahey BB; Pelham WE; Chronis A; Massetti G; Kipp H; Ehrhardt A; Lee SS J Child Psychol Psychiatry; 2006 May; 47(5):472-9. PubMed ID: 16671930 [TBL] [Abstract][Full Text] [Related]
9. [Attention deficit hyperactivity disorder in adults. An overview]. Sobanski E; Alm B Nervenarzt; 2004 Jul; 75(7):697-715; quiz 716. PubMed ID: 15221066 [TBL] [Abstract][Full Text] [Related]
10. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Research Units on Pediatric Psychopharmacology Autism Network Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814 [TBL] [Abstract][Full Text] [Related]
11. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study. Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis. Faraone SV; Biederman J J Atten Disord; 2002 Sep; 6(2):69-75. PubMed ID: 12142863 [TBL] [Abstract][Full Text] [Related]
13. The impact of stimulants on a clinical measure of attention in children with ADHD. Gardner BK; Sheppard DM; Efron D Child Neuropsychol; 2008 Mar; 14(2):171-86. PubMed ID: 17852126 [TBL] [Abstract][Full Text] [Related]
14. Homeopathy for attention deficit/hyperactivity disorder or hyperkinetic disorder. Coulter MK; Dean ME Cochrane Database Syst Rev; 2007 Oct; (4):CD005648. PubMed ID: 17943868 [TBL] [Abstract][Full Text] [Related]
15. European clinical guidelines for hyperkinetic disorder -- first upgrade. Taylor E; Döpfner M; Sergeant J; Asherson P; Banaschewski T; Buitelaar J; Coghill D; Danckaerts M; Rothenberger A; Sonuga-Barke E; Steinhausen HC; Zuddas A Eur Child Adolesc Psychiatry; 2004; 13 Suppl 1():I7-30. PubMed ID: 15322953 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134 [TBL] [Abstract][Full Text] [Related]
17. Neuropsychological functioning in stimulant-naive boys with hyperkinetic disorder. Rhodes SM; Coghill DR; Matthews K Psychol Med; 2005 Aug; 35(8):1109-20. PubMed ID: 16116937 [TBL] [Abstract][Full Text] [Related]
18. Attention-deficit/hyperactivity disorder with obstructive sleep apnea: a treatment outcome study. Huang YS; Guilleminault C; Li HY; Yang CM; Wu YY; Chen NH Sleep Med; 2007 Jan; 8(1):18-30. PubMed ID: 17157069 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder. Neef NA; Bicard DF; Endo S; Coury DL; Aman MG J Appl Behav Anal; 2005; 38(2):135-46. PubMed ID: 16033162 [TBL] [Abstract][Full Text] [Related]
20. Growth in stimulant-naive children with attention-deficit/hyperactivity disorder using cross-sectional and longitudinal approaches. Hanć T; Cieślik J Pediatrics; 2008 Apr; 121(4):e967-74. PubMed ID: 18381524 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]